课题基金 / 基金详情

Research of heat shock protein 47 in lung fibtotic process

Research of heat shock protein 47 in lung fibtotic process
热休克蛋白47在肺纤维化过程中的研究
批准号:
15590817
负责人:
MUKAE Hiroshi
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MUKAE Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
热休克蛋白(HSP)47作为胶原特异性分子伴侣参与了多种胶原蛋白的合成和组装。HSP47在肝硬变和其他纤维化疾病中的表达上调。本文研究了中性粒细胞天青颗粒中具有抗菌和细胞毒活性的阳离子蛋白α防御素对肺成纤维细胞产生热休克蛋白47和胶原的影响,以及热休克蛋白47的表达与肺纤维化过程的关系。首先,我们研究了α-防御素(人中性粒细胞多肽-1)对人肺成纤维细胞HSP47和胶原-1表达的直接影响。5μg/mlHNP-1诱导成纤维细胞增殖,50μg/mlHNP-1抑制细胞活力。当HNP-1浓度为10~25μg/ml时,HSP47和胶原-1mRNA的表达显著增加,蛋白释放量呈剂量依赖性增加。转化生长因子-β也促进了这些基因和蛋白的表达,而吡非尼酮抑制了这些结果。在博莱霉素诱导的小鼠肺纤维化模型中,肺纤维化程度与HSP47mRNA和蛋白的表达有良好的相关性,吡非尼酮可降低Ashcroft评分和羟脯氨酸含量。免疫组织化学研究还可降低肺细胞HSP47、α-SMA和F4/80的表达。提示α-防御素可能通过上调HSP47和胶原-1的表达,直接促进肺成纤维细胞的纤维化进程,在肺纤维化的发病机制中起重要作用,HSP47阳性细胞可能具有促进胶原合成和释放的能力。吡非尼酮抑制这些阳性细胞,这些阳性细胞负责肺纤维化中细胞外基质的积累和沉积。这些发现表明,HSP47和α-防御素可能成为治疗特发性肺纤维化的新靶点。
英文摘要
Heat shock protein(HSP) 47 is involved in the synthesis/assembly of various collagens as a collagen-specific molecular chaperone. HSP 47 expression has been shown upregulated in liver cirrhosis and other fibrotic diseases. We have studied the effect of α-defensin, cationic proteins with antimicrobial and cytotoxic activity in the azurophil granule of neutrophils, on the production of HSP 47 and collagen using lung fibroblasts, and the relationship between HSP47 expression and fibrotic process in murine bleomycin-induced pulmonary fibrosis. At first, we investigated the direct effect of a-defensin (human neutrophil peptide(HNP)-1) on expression of HSP47 and collagen-1 in human lung fibroblasts. HNP-1 5 μg/ml induced fibroblast proliferation and concentrations >50 μg/ml of HNP-1 reduced the cell-viability. Expression of HSP 47 and collagen-1 mRNA was significantly increased by 10 to 25 μg/ml of HNP-1, whereas their protein release increased in dose-dependent manner. TGF-β also enhanced the expression of these mRNA and proteins, and pirfenidone inhibited these findings. In murine bleomycin-induced pulmonary fibrosis, a good correlation was also observed between the degree og pulmonary fibrosis and expression of HSP47 mRNA and proteins and pirfenidone reduced the ashcroft score and hydroxyproline content. It also attenuated expression of HSP 47, a-SMA and F4/80 in lung cells by immunohistochemical study. Our results suggest that α-defensin may promote directly fibrotic process through upregulation of HSP 47 and collagen-1 in human lung fibroblasts and play an important role in the pathogenesis of pulmonary fibrosis and HSP47 positive cells may have an ability of enhanced collagen synthesis and release. Pirfenidone inhibited these positive cells responsible for the accumulation and deposition of extracellular matrix seen in pulmonary fibrosis. These findings suggest that HSP47 and α-defensin might be a new promising target for the treatment of IPF.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
High concentrations of α-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress sydrome
急性呼吸窘迫综合征患者血浆和支气管肺泡灌洗液中高浓度α-防御素
DOI: --
发表时间: 2004
期刊: Life Sci 75-9
影响因子: --
作者: [Ashitani J, Mukae H, et al.]
通讯作者: et al.
DOI: 10.1016/j.rmed.2004.03.008
发表时间: 2004-10-01
期刊: RESPIRATORY MEDICINE
影响因子: 4.3
作者: [Yoshioka, S, Mukae, H, Kohno, S]
通讯作者: Kohno, S
DOI: 10.1183/09031936.04.00120803
发表时间: 2004-07-01
期刊: EUROPEAN RESPIRATORY JOURNAL
影响因子: 24.3
作者: [Kakugawa, T, Mukae, H, Kohno, S]
通讯作者: Kohno, S
Ishii H, Mukae H, et al.: "Increased expression of collagen-binding heat shock protein 47 in murine bleomycin-induced pneumopathy"Am J Physiol Lung Cell Mol Physiol. 285・10. 957-963 (2003)
Ishii H、Mukae H 等人:“小鼠博来霉素诱导的肺炎中胶原蛋白结合热休克蛋白 47 的表达增加”Am J Physiol Lung Cell Mol Physiol 285·10。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 12 条
    Autoantibodies in idiopathic interstitial pneumonias
    • 批准号:
      17K09617
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      MUKAE Hiroshi
    • 依托单位:
    Fundamental study of development of new antibiotics using defensins
    • 批准号:
      20590927
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      MUKAE Hiroshi
    • 依托单位:
    Research of heat shock protein 47 and defensins in the pathogenesis of pulmonary fibrosis
    • 批准号:
      17590795
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2005
    • 负责人:
      MUKAE Hiroshi
    • 依托单位:
    Research of defensins in respiratory infection
    • 批准号:
      13670607
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      2001
    • 负责人:
      MUKAE Hiroshi
    • 依托单位:
    国内基金
    海外基金
    黄精多糖对幽门螺杆菌感染下β-defensin2介导的免疫调节机制研究
    • 批准号:
      LSQN25H280005
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      柳海燕
    • 依托单位:
    灌肠β-defensin-1合成肽通过ILC3逆转结直肠癌细胞PD-1/PD-L1免疫治疗抗性的分子机制研究
    • 批准号:
      82360329
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      赵鹏伟
    • 依托单位:
    多形拟杆菌调控肠道抗菌肽α-defensin分泌干预慢性低度炎症的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      王巧玲
    • 依托单位:
    β-defensin2修饰功能化材料PSeD-M诱导眶骨再生及其机制的研究
    • 批准号:
      81600766
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      庄艾
    • 依托单位: